If authorized, Moderna would put up to 15 doses of the vaccine in the same size vials it now uses to hold 10.
The FDA recently changed Pfizer’s emergency use authorization for its COVID-19 vaccine to specify that its vials contain six doses instead of five, after pharmacists discovered in December they could get an extra dose out of the vials. Moderna’s vials were also found to contain an extra dose, but it is asking the FDA to allow it to add even more to the vials, according to CNBC.
The FDA declined to comment to CNBC, referring questions to Moderna. Moderna didn’t immediately respond to CNBC’s request for comment. Becker’s also has contacted Moderna and will update this article accordingly.
Read the full article here.
More articles on pharmacy:
Eli Lilly COVID-19 antibody drug reduces hospitalizations, death risk, trial shows
1,600 vaccinated within hours after freezer failure at Seattle clinic
J&J says its COVID-19 vaccine is 66% effective
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
